News brief
On 2026/9/23, Presspool reported that UltraSight, an Israeli AI ultrasound imaging company, raised USD 24 million in Series B2 funding, led by Alive HealthTech Growth Fund.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- presspool.ai ↗Published Sep 23, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年9月23日，据Presspool报道，以色列AI超声成像公司UltraSight完成2400万美元B2轮融资，由Alive HealthTech Growth Fund领投。